http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111624085-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-533
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-38
filingDate 2020-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111624085-B
titleOfInvention Sample diluting device and reagent card for detecting novel coronavirus antibody
abstract The invention provides a sample diluting device and a reagent card for detecting a novel coronavirus antibody, wherein the diluting device comprises a diluent sample adding bottle; the diluent sample adding bottle comprises a first diluting cavity and a second diluting cavity which are arranged up and down, the two diluting cavities are separated by an inclined plate, a sample adding hole for inserting a sample collecting pipe is formed in the top of the first diluting cavity, a groove which is communicated up and down is formed in one side of the high end of the inclined plate, and the groove is located right below the sample adding hole; and a liquid outlet is formed at the bottom of the second dilution cavity. The sample diluting device can carry out gradient high-multiple dilution on the antibody in the sample, avoids the barb phenomenon caused by excessive antibody, and is suitable for rapid screening and detection of a large number of novel coronavirus samples; the reagent card can be used for typing detection of IgM and IgG antibodies in blood of a virus infected patient, can also be used for detecting total antibodies of novel coronavirus in blood, and can improve the detection rate of early infected patients.
priorityDate 2020-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03016832-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-209215072-U
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5286454-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414860340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486959
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1041
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID386463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426089005

Total number of triples: 23.